Posted January 7, 2026 at 2:21 pm by globanspharma

Treat non-small cell lung cancer with Retevmo 40mg Capsule

This is a highly selective kinase inhibitor containing selpercatinib. Healthcare professional commonly prescribed Retevmo 40mg Capsule for RET-fusion positive non-small cell lung cancer (NSCLC), medullary thyroid cancer, and other advanced solid tumors. Visit Globans Pharma to know more about the medicine.

On map